Recent advances in the management of colorectal cancer.
Van Cutsem
E
E
Department of Internal Medicine, University Hospital Gosthuisberg, Herestraat 49, BE-3000 Leuven, Belgium. eric.vancutsem@uz.kuleuven.ac.be
Dicato
M
M
Wils
J
J
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000639:trends; D015179:Colorectal Neoplasms / Q000517:prevention & control / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D051231:Farnesyltranstransferase; D006801:Humans; D008222:Lymphokines / Q000037:antagonists & inhibitors; D008403:Mass Screening / Q000379:methods / Q000639:trends; D011379:Prognosis; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000970:Antineoplastic Agents; D016228:Endothelial Growth Factors; D004791:Enzyme Inhibitors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D019883:Alkyl and Aryl Transferases; D051231:Farnesyltranstransferase